Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Mycotoxin produced by species of Aspergillus; D...
Mycotoxin produced by Fusarium fungi that infec...
Steroid; glucocorticoid agonist.
Dihydropyridine; L-type Ca2+ channel blocker.
Calcitonin-family peptide frgament, involved in...
Glycosaminoglycan
Macrolide; protein synthesis inhibitor.
Zinc chelator
Sulforaphane-cysteine conjugate.
Synthetic vasopressin derivative; V2R agonist.<...
B cell epitope found on hepatitis B viral core ...
Endogenous peptide hormone; GnRH agonist.
Indole, glucosinolate found in cruciferous vege...
Glycopeptide, binds D-Ala-D-Ala; cell wall synt...
Protein translation inhibitor.